Skip to main content

 

Select a location

North America

  • US
  • Canada (EN | FR)

Latin America

  • Brazil
  • Colombia
  • Mexico

Asia PaCific

  • Australia
  • Japan

Europe & MENA

  • Benelux
  • Central Eastern Europe
  • France
  • Germany & Austria & Switzerland
  • Greece
  • Italy
  • Middle East & North Africa
  • Nordic & Baltic countries
  • Russia
  • Spain
  • United Kingdom

Locations

  • Home

Countries: ▼

Menu utilisateur

  • Contact us
  • Foundation
Home
Home
Menu
  • About us
    • Our history
    • Rare Diseases & Orphan Drugs
    • Recordati
    • Capabilities
    • Manufacturing plant
    • Executive Management Team
    • Collaborations
    • Gender equity index
    • Join us
  • Products
  • R&D
    • Pipeline
    • The Arrigo Recordati Prize
  • Contact us
  • Clinical Studies
    • Endocrinology

Breadcrumb

  1. Home
  2. News

News

  • Twitter
  • Facebook
  • Linked in
  • Mail

Recordati completes the acquisition of EUSA Pharma (UK)

03/16/2022
  Read more here  
  Read more here  

Recordati to acquire EUSA Pharma (UK) Ltd, a global specialty pharmaceutical company focused on rare and niche oncology diseases

12/03/2021
  Read more here  
  Read more here  

Andrea Recordati appointed Chairman and Robert Koremans appointed Chief Executive Officer

12/01/2021
  Read more here  
  Read more here  

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

Logo rrd 2023

  Linkedin

Informations

  • Legal Information
  • Transparency
  • Sosyal Medya
  • Corporate Compliance
  • Social Media

® 2025 Recordati Rare Diseases All rights reserved.

Tweets by RecordatiD
  • About us
    • Our history
    • Rare Diseases & Orphan Drugs
    • Recordati
    • Capabilities
    • Manufacturing plant
    • Executive Management Team
    • Collaborations
    • Gender equity index
    • Join us
  • Products
  • R&D
    • Pipeline
    • The Arrigo Recordati Prize
  • Contact us
  • Clinical Studies
    • Endocrinology